[Clinical study of erythromycin ascorbate for parenteral use].
D000328:Adult; D001205:Ascorbic Acid / Q000627:therapeutic use*; D002761:Cholangitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D005658:Fungi / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007239:Infections / Q000188:drug therapy*; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D008590:Meningoencephalitis / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D014556:Urine / Q000382:microbiology
D004917:Erythromycin; D001205:Ascorbic Acid
Klinicheskoe izuchenie askorbata éritromitsina DLIA PARENTERAL'nogo primeneniia.